Category: Uncategorized
-
Podcast on SEP enforcement in Latin America with experienced Brazilian, Colombian patent litigators
Brazil and Colombia have become increasingly attractive venues for standard-essential patent (SEP) enforcement. In the past 12 months, Brazil has become a particularly popular venue for major international patent infringement disputes. In some of those cases, such as ZTE v. Samsung, the courts also awarded the patentee a preliminary injunction (PI) (February 13, 2025 ip…
-
EU Commission gets support from 10 Member States for withdrawal of proposed SEP Regulation; 9 don’t care; only 8 want to keep it alive
Context: A little over two weeks ago, the European Commission (EC) withdrew its proposal for a regulation on standard-essential patents (February 11, 2025 ip fray article). A footnote to the EC’s working program noted that pending legislative proposals would be withdrawn within six months. Yesterday the Working Group on IP of the EU Council (the…
-
Agendas now out for IP Dealmakers Europe + LF Dealmakers Europe (London, June 23-25)
The Super Early Bird rate is still available for the 2nd annual IP/LF Dealmakers Forums Europe (IP and litigation finance) for those who register by March 21. ip fray is the official media partner.
-
UPC, German and other courts should thwart UK ‘interim license’ imperialism with ex parte preliminary injunctions over any affected patents
Context: The England & Wales Court of Appeal (EWCA) appears to have zero regard for other jurisdictions when it wants the UK to become the world’s sole arbiter for FRAND (fair, reasonable and non-discriminatory) licensing terms by ordering standard-essential patent (SEP) holders to grant interim licenses (even potentially including non-SEPs) in an effort to prevent…
-
“Some say power over people… I say achieving through and with people”: an interview with Bayer’s IP head Dr. Jörg Thomaier
In this interview, Dr. Jörg Thomaier, CEO of Bayer IP GmbH, reflects on over 27 years at the pharma giant, including helping transform the patent team from being a somewhat “neglected child” into a respected, functioning engine for the overall company.
-
An interview with Johnson & Johnson’s departing VP of MedTech IP Strategy Paul Coletti
In this interview, Paul Coletti, (now former) VP of MedTech IP Strategy at Johnson & Johnson, shares the highlights of his 37 years in the company’s IP department, and the basis of successful leadership.
-
Swedish pharma giant Orexo settles Zubsolv patent dispute with Sun Pharmaceutical weeks before Federal Circuit appellate hearing
The Federal Circuit was due to hear Sun Pharmaceutical’s appeal against a District Court of New Jersey bench ruling finding it infringed Orexo’s Zubsolv patents on January 7, 2025.
-
Fractus files fresh IoT-related patent litigation, sues Geotab and Verizon in Eastern District of Texas
Lawsuits come after three successful patent licensing deals in the IoT market this year.
-
Via LA launches new voice codec pool: Dolby, ETRI, Huawei, JVCKenwood and NTT already on board
Huawei has also taken a license from Via LA’s new pool, which covers voice technologies such as EVS and IVAS.
-
China’s IP finance push reaches new heights but hits patent transaction data stumbling block
China’s IP-backed lending market now stands at USD$109 billion but its government is struggling to collect data on patent transactions to help expedite in-house, accurate valuation.